Skip to main content
Cornell University
We gratefully acknowledge support from the Simons Foundation, member institutions, and all contributors. Donate
arxiv logo > q-bio > arXiv:1306.4842

Help | Advanced Search

arXiv logo
Cornell University Logo

quick links

  • Login
  • Help Pages
  • About

Quantitative Biology > Tissues and Organs

arXiv:1306.4842 (q-bio)
[Submitted on 20 Jun 2013]

Title:Maximum Tolerated Dose Versus Metronomic Scheduling in the Treatment of Metastatic Cancers

Authors:Sebastien Benzekry (CCSB), Philip Hahnfeldt (CCSB)
View a PDF of the paper titled Maximum Tolerated Dose Versus Metronomic Scheduling in the Treatment of Metastatic Cancers, by Sebastien Benzekry (CCSB) and 1 other authors
View PDF
Abstract:Although optimal control theory has been used for the theoretical study of anti-cancerous drugs scheduling optimization, with the aim of reducing the primary tumor volume, the effect on metastases is often ignored. Here, we use a previously published model for metastatic development to define an optimal control problem at the scale of the entire organism of the patient. In silico study of the impact of different scheduling strategies for anti-angiogenic and cytotoxic agents (either in monotherapy or in combination) is performed to compare a low-dose, continuous, metronomic administration scheme with a more classical maximum tolerated dose schedule. Simulation results reveal differences between primary tumor reduction and control of metastases but overall suggest use of the metronomic protocol.
Subjects: Tissues and Organs (q-bio.TO); Analysis of PDEs (math.AP)
Cite as: arXiv:1306.4842 [q-bio.TO]
  (or arXiv:1306.4842v1 [q-bio.TO] for this version)
  https://doi.org/10.48550/arXiv.1306.4842
arXiv-issued DOI via DataCite

Submission history

From: Sebastien Benzekry [view email] [via CCSD proxy]
[v1] Thu, 20 Jun 2013 12:08:17 UTC (4,674 KB)
Full-text links:

Access Paper:

    View a PDF of the paper titled Maximum Tolerated Dose Versus Metronomic Scheduling in the Treatment of Metastatic Cancers, by Sebastien Benzekry (CCSB) and 1 other authors
  • View PDF
  • Other Formats
view license
Current browse context:
q-bio.TO
< prev   |   next >
new | recent | 2013-06
Change to browse by:
math
math.AP
q-bio

References & Citations

  • NASA ADS
  • Google Scholar
  • Semantic Scholar
a export BibTeX citation Loading...

BibTeX formatted citation

×
Data provided by:

Bookmark

BibSonomy logo Reddit logo

Bibliographic and Citation Tools

Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)

Code, Data and Media Associated with this Article

alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)

Demos

Replicate (What is Replicate?)
Hugging Face Spaces (What is Spaces?)
TXYZ.AI (What is TXYZ.AI?)

Recommenders and Search Tools

Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
  • Author
  • Venue
  • Institution
  • Topic

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)
  • About
  • Help
  • contact arXivClick here to contact arXiv Contact
  • subscribe to arXiv mailingsClick here to subscribe Subscribe
  • Copyright
  • Privacy Policy
  • Web Accessibility Assistance
  • arXiv Operational Status
    Get status notifications via email or slack